Literature DB >> 18508628

MSK activation and physiological roles.

J Simon C Arthur1.   

Abstract

Mitogen and stress activated protein kinase (MSK) 1 and 2 are nuclear serine/threonine protein kinases that are activated in vivo downstream of either the ERK1/2 or p38 mitogen activated protein kinase (MAPK) cascades. MSKs contain two kinase domains, an N-terminal kinase domain related to the AGC kinase family, and a C-terminal kinase domain related to the CaMK family. The upstream MAPK phosphorylates the C-terminal domain, which then phosphorylates and activates the N-terminal domain. Once activated, the N-terminal domain phosphorylates substrates. MSKs do not have a precisely defined substrate consensus sequence, however the do have a preference for a basic cluster prior to the phosphorylated residue. In cells MSKs phosphorylate several substrates including CREB, NFkB, HMGN1 and histone H3. The major role of MSKs appear to be in the regulation of immediate early (IE) genes, and consistent with this the transcription of several CRE dependent IE genes is compromised in MSK knockouts. The physiological roles of MSKs still remain to be completely determined, however recent work has suggested a role for MSKs in neuronal synaptic plasticity and in regulating cytokine production in the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508628     DOI: 10.2741/3122

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  77 in total

Review 1.  Controlling gene expression in response to stress.

Authors:  Eulàlia de Nadal; Gustav Ammerer; Francesc Posas
Journal:  Nat Rev Genet       Date:  2011-11-03       Impact factor: 53.242

Review 2.  The role of histone acetylation in memory formation and cognitive impairments.

Authors:  Lucia Peixoto; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

4.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

5.  Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; Paula S Espino; Shihua He; Soma Mandal; Shannon Healy; James R Davie
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

Review 6.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

7.  MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.

Authors:  Kirsty F MacKenzie; Mirjam W M Van Den Bosch; Shaista Naqvi; Suzanne E Elcombe; Victoria A McGuire; Alastair D Reith; Perry J Blackshear; Jonathan L E Dean; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

8.  cAMP-response element-binding protein (CREB) controls MSK1-mediated phosphorylation of histone H3 at the c-fos promoter in vitro.

Authors:  Miho Shimada; Tomoyoshi Nakadai; Aya Fukuda; Koji Hisatake
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

9.  PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway.

Authors:  Kirsty F MacKenzie; Kristopher Clark; Shaista Naqvi; Victoria A McGuire; Gesa Nöehren; Yosua Kristariyanto; Mirjam van den Bosch; Manikhandan Mudaliar; Pierre C McCarthy; Michael J Pattison; Patrick G A Pedrioli; Geoff J Barton; Rachel Toth; Alan Prescott; J Simon C Arthur
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

10.  Traumatic brain injury induces a downregulation of MSK1 in rat brain cortex.

Authors:  Bo Ning; Zhen Li; Ningxi Zhu; Gang Hou; Qi Pang
Journal:  J Mol Neurosci       Date:  2012-10-11       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.